MedAmicus' LuMax Uroflow system introduced:
This article was originally published in Clinica
Minnesota-based MedAmicus (US) has introduced its LuMax Uroflow system and other enhancements for the LuMax fibre optic cystometry system. The Uroflow allows uroflow and pressure flow studies to determine appropriate therapies for male patients with obstructed voiding due to benign prostatic hyperplasia. Other enhancements introduced at the AUA include reusable fibre optic catheters and a volume infused transducer for marking infused volume of saline at key diagnostic events.
You may also be interested in...
Data show Opdivo/Cabometyx combo bests Sutent for overall and progression-free survival and response endpoints in first-line RCC. Exelixis CEO says comparison to Sutent is standard control and allows better comparison to other combo regimens.
ES: Public Company Edition: Fifty biopharma companies launched initial public offerings in the US last year and there have been 52 so far in 2020, including Metacrine, Dyne, Athira and COMPASS.
In an update to stakeholders, the US FDA says regulators can successfully evaluate a firm’s performance, allowing it to eventually get medical software to market in the agency’s Pre-Cert Program.